Though both markers showed promising predictive values, the observed sensitivity and specificity values for both interleukins are lower that 80%, implicating that IL-17A and IL-23A serum levels failed to exhibit good accuracy in diagnosing GAD patients. Here, IL17A is linked to generalized anxiety disorder.